Search
for
Sort by
Research 841–870 of 1000+
- A case study on successful Ayurvedic management of polycystic ovarian syndrome (PCOS) induced infertility
- Epidemiological profile of patients presenting to dermatology department of a tertiary care hospital during nationwide lockdown due to COVID-19: a retrospective study from north India
- Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin
- Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous adenitis
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- COVID-19 Severity and Androgen Receptor Polymorphism
- Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
- Quality of Life with Alopecia Areata versus Androgenetic Alopecia Assessed Using Hair Specific Skindex-29
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- A simple method using ex vivo culture of hair follicle tissue to investigate intrinsic circadian characteristics in humans
- Therapeutic management of hypothyrodism with concurrent babesiosis in a non-descript dog
- 52874 Timing of eyebrow and eyelash regrowth among subgroups of scalp responders during treatment of severe alopecia areata with baricitinib
- Severe Abnormalities in the Oral Mucosa Induced by Suprabasal Expression of Epidermal Keratin K10 in Transgenic Mice
- Complex application of high-intensity phototechnologies in the treatment of diffuse alopecia
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata
- Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study
- Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
- The histopathology of alopecia areata in vertical and horizontal sections
- Management of hair loss diseases
- Lack of Response to Laser Comb in Spontaneous and Graft-Induced Alopecia Areata in C3H/HeJ Mice
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment